AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 99 filers reported holding AVROBIO INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $82,000 | -44.2% | 21,176 | -19.8% | 0.00% | – |
| Q3 2021 | $147,000 | -29.0% | 26,403 | +13.7% | 0.00% | – |
| Q2 2021 | $207,000 | -25.3% | 23,230 | +6.3% | 0.00% | – |
| Q1 2021 | $277,000 | 0.0% | 21,855 | +10.2% | 0.00% | – |
| Q4 2020 | $277,000 | +13.5% | 19,836 | +6.0% | 0.00% | – |
| Q3 2020 | $244,000 | -25.8% | 18,708 | 0.0% | 0.00% | – |
| Q2 2020 | $329,000 | +43.0% | 18,708 | +26.6% | 0.00% | – |
| Q1 2020 | $230,000 | -13.2% | 14,773 | +12.3% | 0.00% | – |
| Q4 2019 | $265,000 | +34.5% | 13,160 | +1.4% | 0.00% | – |
| Q3 2019 | $197,000 | +15.2% | 12,984 | +23.8% | 0.00% | – |
| Q2 2019 | $171,000 | – | 10,490 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,736,027 | $45,555,000 | 28.05% |
| Aisling Capital Management LP | 736,998 | $12,271,000 | 12.93% |
| Cormorant Asset Management, LP | 1,357,784 | $22,607,000 | 1.84% |
| New Leaf Venture Partners, L.L.C. | 215,550 | $3,589,000 | 0.98% |
| Eventide Asset Management | 928,891 | $14,901,000 | 0.66% |
| EMERALD ADVISERS, LLC | 380,636 | $6,338,000 | 0.31% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 372,865 | $6,208,000 | 0.29% |
| Blackstone Inc. | 2,962,325 | $49,323,000 | 0.28% |
| PFM Health Sciences, LP | 241,413 | $4,020,000 | 0.11% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 143,762 | $2,394,000 | 0.10% |